yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital..

scottish widows has its eyes on the master trust prize.

it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done..